Thermo Fisher Scientific Inc. announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry.

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...

The risk for alopecia areata is increased among patients with lower serum levels of vitamin D and zinc, but no relationship was observed with copper.

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

Stress can lead to noticeable hair loss, usually months after a stressful situation occurs. This type of hair loss is ...

The short answer is yes. Stress is considered an "initiating event" that contributes to hair loss. Learn how hair loss from stress happens in this article.

HCW Biologics shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration ...

But why do men go bald? When do men go bald? And can you stop or reverse balding? We’ll answer all these questions and more ...

A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, ...

Hair loss is a common issue that affects millions of people worldwide causing emotional distress diminished self-esteem and social anxiety Whether due to genetic factors hormonal imbalances medical co ...

MIRAMAR, Fla. - HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical company with a market capitalization of approximately $12.4 million, announced today that it has received U.S.